TAIPEI , May 28, 2024 /PRNewswire/ -- Genovate Biotechnology Co., Ltd. (TPEx: 4130), a Taiwan -based specialty pharmaceutical company, today announced its plans to submit a New Drug Application (NDA) with the United States Food and Drug ...
BE HEARD I and BE HEARD II are the first Phase 3 trials to evaluate the efficacy and safety of an IL-17A and IL–17F inhibitor, BIMZELX ® (bimekizumab-bkzx), in the treatment of adult patients with moderate-to-severe hidradenitis suppurativa ...
AMSTERDAM , May 23, 2024 /PRNewswire/ -- The race to create replacement antibiotics and antifungals to combat superbugs is falling dangerously short, putting people across the world at risk. However, a shift in research and development ...
SUZHOU, China , May 21, 2024 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, proudly announces that its flagship program, RAG-01, has been granted Fast Track Designation (FTD) by ...
SAN FRANCISCO and SUZHOU, China , May 20, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
SOUTH SAN FRANCISCO, Calif. , May 20, 2024 /PRNewswire/ -- Rila Therapeutics, Inc., A biotechnology company focused on addressing the burden of chronic fibrotic diseases, today announced that the first cohort of subjects was dosed in a ...
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) will direct a team of researchers to investigate a novel oral vaccine for chlamydia, the most reported sexually transmitted disease, with funding from the ...
Proceeds from financing to support ongoing clinical development of lead program targeting PVR as well as IND-enabling activities for multiple ADC candidates TEL AVIV, Israel , May 6, 2024 /PRNewswire/ -- Guangzhou-Israel ...
A real-world evidence (RWE) study recently published in Open Forum Infectious Diseases (OFID) examined three consecutive U.S. flu seasons in the United States . The study suggests that cell-based quadrivalent influenza vaccine (QIVc) may ...
TAIPEI , April 30, 2024 /PRNewswire/ -- Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced that the first subject has been dosed in its Phase 1 clinical trial of FP-020 in Australia . The Phase 1 clinical trial is a ...
In a concerning revelation, the utilization of popular diabetes and weight loss drugs has been associated with an elevated risk of stomach paralysis, a rare yet severe condition known as gastroparesis . Emerging from comprehensive ...
Semaglutide , as highlighted by a groundbreaking study, offers substantial benefits by reducing the risk of major kidney disease events, cardiovascular outcomes, and all-cause mortality in patients diagnosed with type 2 diabetes and chronic kidney disease ( )....
In response to the worldwide surge in H5N1 cases, American researchers have created an experimental mRNA vaccine , leveraging COVID-19 vaccine technology, to combat avian flu infections ( ). Preclinical models, detailed in the journal Nature ...
The type 2 diabetes and obesity market for GLP-1R agonists is expected to reach $125 billion in 7 major markets by 2033. This estimation has been projected by GlobalData, a leading data and analytics company ( ). Glucagon-like ...
Blood pressure medications significantly elevate the risk of life-threatening bone fractures, as per research by Rutgers Health published in JAMA Internal Medicine. The...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers